DexCom, Inc. DXCM today announced that management will present an update on DexCom at the following upcoming investor conference:
- Steven Pacelli, Executive Vice President, Strategy and Corporate Development, and Matthew Dolan, Vice President Corporate Development, will present on behalf of the company at the William Blair 38th Annual Growth Stock Conference in Chicago, Illinois on Tuesday, June 12, 2018 at 7:30am (CDT). The presentation, which will occur live at the Four Seasons Hotel, will be concurrently webcast.
The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to "Our Company," then "Investor Relations," and finally "Events and Webcasts" and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180517005314/en/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.